Hi all,
I haven't held this stock for a few years, but always keep an eye on it.
Yes, this seems at odds with the recent 4C. New (and old) investors would not have been expecting a CR based of the 4 C implying/stipulating they have enough cash to advance RAP through commercialisation.
With FDA Ann expected soon, clearly it seems management are not that confident. With FDA approval, they would likely raise cash at multiples of of the current SP, limiting dilution.
Seems like they are hedging their bets to me. If they have a suspicion that FDA will fail (or take many many more months) then raising cash at circa 24c is better than 15c (with FDA delay) or 10c (with FDA failure).
Just my thoughts.
Good luck all.
- Forums
- ASX - By Stock
- RAP
- Ann: Trading Halt
Ann: Trading Halt, page-52
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 299 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online